Mark Bach
Institution Name:
Total Awards:
1
Award Value:
$7,766,382
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | GentiBio | A Phase 1 study of an engineered Treg cell therapy, GNTI-122, in adults with recently diagnosed Type 1 Diabetes | $7,766,382 |
| Total: $7,766,382.00 |